Multiple alternate p21 transcripts are regulated by p53 in human cells

被引:33
|
作者
Radhakrishnan, SK [1 ]
Gierut, J [1 ]
Gartel, AL [1 ]
机构
[1] Univ Illinois, Dept Med, Chicago, IL 60612 USA
关键词
p21; alternate transcript; p53; basal transcription;
D O I
10.1038/sj.onc.1209195
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 tumor-suppressor is a transcription factor that is stabilized in response to cellular stress leading to growth arrest or apoptosis. p21(WAF1/CIP1) is a major transcriptional target of p53 and it plays a critical role in p53-dependent cell cycle arrest. In this study, we identified multiple alternate human p21 transcripts that have their transcriptional start sites in the direct proximity of the distal p53 response element. These transcripts are upregulated as a result of DNA damage-induced p53 activation. Furthermore, the basal expression of these alternate transcripts is strongly regulated by p53 and they are undetectable in p53-knocked down cells. This is in contrast to classical p21 transcripts, which have reduced, albeit detectable expression levels in the absence of p53. The existence of the alternate transcripts underscores the complexity of the human p21 genomic locus and opens up new avenues for further investigation.
引用
收藏
页码:1812 / 1815
页数:4
相关论文
共 50 条
  • [1] Multiple alternate p21 transcripts are regulated by p53 in human cells
    S K Radhakrishnan
    J Gierut
    A L Gartel
    [J]. Oncogene, 2006, 25 : 1812 - 1815
  • [2] Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin
    Ravizza, R
    Gariboldi, MB
    Passarelli, L
    Monti, E
    [J]. BMC CANCER, 2004, 4 (1)
  • [3] Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin
    Raffaella Ravizza
    Marzia B Gariboldi
    Laura Passarelli
    Elena Monti
    [J]. BMC Cancer, 4
  • [4] Expression of p53 and p21 in primary glioblastomas
    Gross, MW
    Kraus, A
    Nashwan, K
    Mennel, HD
    Engenhart-Cabillic, R
    Schlegel, J
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 (03) : 164 - 171
  • [5] Induction of p21 by p65 in p53 null cells treated with Doxorubicin
    Ma, Shenglin
    Tang, Juanjuan
    Feng, Jianguo
    Xu, Yaping
    Yu, Xinmin
    Deng, Qinghua
    Lu, Yanjun
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2008, 1783 (05): : 935 - 940
  • [6] Immunohistochemical study of p53, p21 and PCNA in pterygium
    Ueda, Y
    Kanazawa, S
    Kitaoka, T
    Dake, Y
    Ohira, A
    Ouertani, AM
    Amemiya, T
    [J]. ACTA HISTOCHEMICA, 2001, 103 (02) : 159 - 165
  • [7] Association of p53 and p21 polymorphisms with prostate cancer
    Sivonova, Monika Kmetova
    Vilckova, Marta
    Kliment, Jan
    Mahmood, Silvia
    Jurecekova, Jana
    Dusenkova, Svetlana
    Waczulikova, Iveta
    Slezak, Peter
    Dobrota, Dusan
    [J]. BIOMEDICAL REPORTS, 2015, 3 (05) : 707 - 714
  • [8] The Role of p21 and p53 Proteins in Congenital Cholesteatoma
    Olszewska, Ewa
    Rutkowska, Justyna
    Minovi, Amir
    Sieskiewicz, Andrzej
    Rogowski, Marek
    Dazert, Stefan
    [J]. OTOLOGY & NEUROTOLOGY, 2013, 34 (02) : 266 - 274
  • [9] p21 governs p53's repressive side
    Fischer, Martin
    [J]. CELL CYCLE, 2016, 15 (21) : 2852 - +
  • [10] Expressions of p53 and p21 in primary gastric lymphomas
    Go, JH
    Yang, WI
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2001, 16 (06) : 731 - 735